Navigation Links
Misonix Reports Financial Results for First Half of Fiscal 2013
Date:2/7/2013

cts, BoneScalpel, SonicOne and SonaStar revenue increased 46% for the six months ended December 31, 2012. We are pleased with that performance."

"Bottom-line results were impacted by an unfavorable product mix of low and high margin product deliveries, additional headcount as we continue to invest in our sales and marketing team, and increased selling expenses as more distributors become engaged in selling our products. We expect that these impacts will be offset as we continue to grow revenues in the coming quarters."

Mr. McManus concluded, "The financial base of the Company continues to be strong with $6.9 million in cash and equivalents and zero long-term debt. We continue to make progress in expanding our business both domestically and internationally. While we are still in the early stages of executing on our plan as a focused medical device company, we are pleased with the progress made to date."

Conference Call:Michael A. McManus Jr., President and Chief Executive Officer, and Richard Zaremba, Senior Vice President and Chief Financial Officer, will host a conference call Thursday, February 7, 2013 at 4:30 pm ET to discuss the financial results of the first half of fiscal 2013.

Shareholders and other interested parties can access the conference call by dialing (877) 317-6789 or (412) 317-6789 or can listen via a live Internet webcast, which is available in the Investor Relations section of the Company's website at www.misonix.com.

A teleconference replay of the call will be available for three days at (877) 344-7529 or (412) 317-0088, confirmation # 10024916. A webcast replay will be available in the Investor Relations section of the Company's website at www.misonix.com for 30 days.

About Misonix:Misonix, Inc. designs, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis
'/>"/>

SOURCE Misonix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Misonix Presents at MicroCapClub Invitational
2. Misonix Terminates Distribution Agreement With Aesculap
3. Misonix Reports Strong Revenue Increases for the First Quarter of Fiscal 2013
4. Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012
5. Misonix Product Featured At Neurosurgery Congress
6. Misonix Adds 6 Spine Sales Agencies In The U.S.
7. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
8. Misonix Inks New Distribution Agreement For Croatia And Slovenia
9. Misonix And Soelim Create New Distribution Alliance For South Korea
10. Misonix Participates In Cleveland Spine Review
11. Misonix Adds Industry Veteran To Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
(Date:1/15/2014)... Ill. , Jan. 15, 2014 The Cadence ... Medical Fitness Center by the Medical Fitness Association, a ... to achieve their full potential. The Cadence Fitness & ... the western suburbs and second in the Chicagoland area. ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... ATLANTA, Nov. 28, 2011   CardioMEMS, Inc ., an ... commercializing a proprietary wireless sensing and communication technology for ... CEO, Jay Yadav, M.D. , has been recognized ... Endeavor Awards in the Technology Entrepreneur category. The awards ...
... (NYSE Amex: PIP ), a biodefense company ... today that Eric I. Richman, President and Chief Executive ... Healthcare Conference being held November 29-30, 2011.  ... in one-on-one meetings at the conference.Event : , ...
Cached Medicine Technology:TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist 2TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist 3PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011 2
(Date:4/17/2014)... TORONTO, April 17, 2014 Giving patients adrenaline after they ... not increase their prospects of surviving long-term, according to ... vast number of patients who have a cardiac arrest ... treating cardiac arrest for decades," said Dr. Steve Lin, ... Michael,s. "Yet, despite advances in medical treatment, long-term survival ...
(Date:4/16/2014)... 15, 2014 The Translational Genomics Research Institute (TGen) ... Founders Dinner for their support of TGen,s research into ... March 28 in Scottsdale. , Catherine Ivy, Founder and ... TGen,s John S. McCain Leadership Award, named for U.S. ...
(Date:4/15/2014)... pre-diabetes in the United States have nearly doubled since 1988, ... Public Health, with obesity apparently to blame for the surge. ... has not hit all groups equally, with alarming increases in ... new research reported in the April 15, 2014 issue of ...
(Date:4/14/2014)... over the past decade, but targeting drugs to cancer ... major challenge. , Nanotechnology has unlocked new pathways ... or capsules, that can transport cargoes of small-molecule therapeutics ... These carriers are tiny, and it matters just how ...
(Date:4/14/2014)... IL A new study shows that moderate to severe obstructive ... cancer and death. , Results of the 20-year follow-up study show ... times more likely to die (hazard ratio = 4.2), nearly four ... times more likely to die from cancer (HR = 3.4), and ...
Breaking Medicine News(10 mins):Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Nano shake-up 2Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2
... Awareness of Lupus and ... Funds for Lupus Foundation of America, WASHINGTON, Sept. 13 ... Houston, Texas, two recent,college graduates, will end their 15 week ... 4,000 miles from Bellingham,Washington to Charleston, South Carolina. The ...
... Novelli as MDMA,s Director of Federal Affairs, ... (MDMA) is pleased to announce the appointment of,Thomas ... Affairs., (Photo: http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO ), ... Senate Committee on Finance,for Senator Charles Grassley from ...
... explores industry trends and the utilization of ... 13 Visiprise, Inc., a leader in,manufacturing execution ... the company will host a series of podcast ... Titled "Operational,Efficiency in Medical Device Manufacturing," these free, ...
... SAN DIEGO, Sept. 13 NuVasive, Inc. (Nasdaq:,NUVA), ... for,minimally disruptive surgical treatments for the spine, announced ... and Kevin,O,Boyle, Executive Vice President and Chief Financial ... 5th Annual Growth,Conference at the St. Regis Hotel, ...
... China,Shenghuo Pharmaceutical Holdings, Inc. ("China Shenghuo," "the ... in the research, development, manufacture,and marketing of ... People,s Republic of China ("PRC"), today announced ... Chinese herbal skin care,products ("12Ways") on Sunday, ...
... Education Council raises awareness about prostate cancer ... and related health concerns, ... he,has prostate cancer -- the second-leading cause of cancer death in ... making prostate,cancer among men more prevalent than breast cancer among women. ...
Cached Medicine News:Health News:Bike Ride Across the U.S. to End Saturday at Folly Beach 2Health News:MDMA Names New Director of Federal Affairs 2Health News:Visiprise Launches Podcast Series with AMR to Support Medical Device Manufacturers 2Health News:NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference 2Health News:NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 2Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 4Health News:Prostate Cancer Awareness Week to Screen Thousands 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: